MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick

MEDPATE HOLDINGS INC (NASDAQ:MEDP) has become an interesting option for investors using systematic growth plans, joining Mark Minervini's strict trend-following system with fundamental growth momentum checks. The selection process finds stocks showing both solid technical traits via Minervini's Trend Template and strong fundamental growth measures through ChartMill's High Growth Momentum rating, forming a two-part filter that looks for companies having both price momentum and foundational business health.

Meeting the Minervini Trend Template Criteria

MEDP shows very good fit with Minervini's technical needs, which concentrate on finding stocks in solid, lasting upward moves. The Trend Template's moving average structure shows a stock set for continued strength:

• Current price of $546.74 trades well above the 150-day MA ($383.85) and 200-day MA ($372.68)
• Both the 150-day and 200-day moving averages show upward paths
• The 50-day MA ($497.28) sits comfortably above both longer-term averages
• Price sits 118% above its 52-week low of $250.05 while remaining within 1.3% of its 52-week high
• Relative strength ranking of 91.48 indicates better performance compared to nearly 92% of all stocks

These technical traits match Minervini's idea that stocks in Stage 2 advances, marked by rising moving averages and good relative strength, present the most attractive risk-reward setups. The template's moving average structure makes sure investors are taking part in confirmed upward moves instead of trying to catch falling prices or find bargains in declining stocks.

Fundamental Growth Momentum Drivers

Beyond technical health, MEDP displays the fundamental speed that growth investors look for. The company's earnings and revenue path shows the type of operational quality that usually supports lasting price gains:

• EPS growth of 25.2% over the trailing twelve months shows solid profitability increase
• Quarterly EPS growth sped up to 28.2% in the most recent quarter
• Revenue growth of 23.7% in the latest quarter indicates good top-line momentum
• Profit margins stay healthy at 15.0% in the most recent quarter
• Analyst sentiment has become more positive with next-year EPS estimates changed upward by 10.3% over the past three months

This fundamental picture matches Minervini's focus on companies having earnings speed increases and positive estimate changes, factors that often come before institutional buying and further price gains. The mix of good technicals and speeding up fundamentals creates a strong setup where price movement confirms foundational business health.

Industry Leadership and Market Position

As a provider of clinical development services to biotechnology, pharmaceutical, and medical device companies, MEDP works in a growing field with important barriers to entry. The company's global presence across North America, Europe, and Asia places it to benefit from rising outsourcing in clinical research. Its steady performance has turned into stock results that rank in the top ten percent of all stocks and do better than 87% of similar companies in the Life Sciences Tools & Services industry.

Technical Assessment Summary

The technical analysis report gives MEDP a top rating of 10 out of 10, showing very good technical condition across several time periods. Both short-term and long-term trends stay positive, with the stock trading near its 52-week high of $554.14. The setup rating of 7 indicates the stock is now in a resting phase inside its larger upward move, possibly giving a good entry point for momentum investors. Support levels are clearly set between $523.50 and $527.75, giving defined risk management points.

View the complete technical analysis report for MEDP for full support and resistance levels, volume study, and other trading points.

Finding Similar Opportunities

Investors looking for other choices that meet this strict mix of technical and fundamental requirements can use the High Growth Momentum + Trend Template screen for regularly refreshed results that sort for stocks displaying both Minervini Trend Template qualifications and high growth momentum traits.

Disclaimer: This analysis is for informational and educational purposes only and should not be considered as investment advice. All investments involve risk, and past performance is no guarantee of future results. Conduct your own research and consult with a qualified financial advisor before making any investment decisions.